|5.92||+0.24 / +4.23%|
As of 4:00pm ET
|5.92||0.00 / 0.00%|
The 6 analysts offering 12-month price forecasts for Pernix Therapeutics Holdings Inc have a median target of 12.50, with a high estimate of 19.00 and a low estimate of 8.50. The median estimate represents a +111.15% increase from the last price of 5.92.
The current consensus among 6 polled investment analysts is to Buy stock in Pernix Therapeutics Holdings Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.